Intralesional bleomycin as alternative therapy in the treatment of multiple basal cell carcinomas.
An 82-year-old female with with multiple basal cell carcinomas is presented. Her history includes treatment for similar lesions for 15 years with surgical and X-ray methods. We injected intralesional bleomycin to eight new histologically proven basal cell cancers. A followup at 2 years demonstrates the effectiveness of this therapy.
Gyurova
Magdalina Stoyanova
MS
Stancheva
Marieta Zheleva
MZ
Arnaudova
Monka Nedelcheva
MN
Yankova
Rumiana Kalopherova
RK
D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage* / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D016609:Neoplasms, Second Primary / Q000188:drug therapy* / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D001761:Bleomycin